All In Biotech

Free tool

FAERS Monitor: Prilosec Otc

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021229 or its brand name (Prilosec Otc, Omeprazole Magnesium). Reports on generic versions are filed under their own applications.

Reports

31,002

Serious

23,793

77% of reports

Hospitalization

3,499

Death reported

2,661

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • chronic kidney disease18,104
  • acute kidney injury9,430
  • renal failure7,624
  • end stage renal disease5,802
  • renal injury5,352
  • tubulointerstitial nephritis2,343
  • hyperchlorhydria2,167
  • pain2,132
  • rebound effect2,006
  • gastrooesophageal reflux disease1,959
  • drug ineffective1,699
  • drug dependence1,679
  • nephrogenic anaemia1,509
  • death1,335
  • rebound acid hypersecretion1,292

Reports by year received

View as table
YearReports
200437
200555
200665
200787
2008229
2009603
2010438
2011691
20121,229
2013623
2014570
2015683
2016634
2017538
20189,084
20198,419
20202,576
20211,906
2022660
2023373
2024390
2025582
2026530

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,157 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rebound acid hypersecretionSignal1,292504.7470.0372,117
hyperchlorhydriaSignal2,167394.6374.7537,716
nephrogenic anaemiaSignal1,509327.1308.0330,824
end stage renal diseaseSignal5,802315.9306.81,243,317
chronic kidney diseaseSignal18,104211.8209.22,905,026
renal injurySignal5,352148.8144.8645,127
rebound effectSignal2,006146.2139.5237,949
tubulointerstitial nephritisSignal2,34396.892.8194,435
acute kidney injurySignal9,43044.543.7378,863
renal failureSignal7,62441.340.4284,074
gastrooesophageal reflux diseaseSignal1,95916.916.228,679
drug dependenceSignal1,6797.16.88,848
painSignal2,1322.42.31,713
death1,3351.11.03
drug ineffective1,6990.90.832

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.